Remote ischemic preconditioning STAT3-dependently ameliorates pulmonary ischemia/reperfusion injury

PloS One
Nanfu LuoGeoffrey W Abbott

Abstract

The lungs are highly susceptible to injury, including ischemia/reperfusion (I/R) injury. Pulmonary I/R injury can occur when correcting conditions such as primary pulmonary hypertension, and is also relatively common after lung transplantation or other cardiothoracic surgery. Methods to reduce pulmonary I/R injury are urgently needed to improve outcomes following procedures such as lung transplantation. Remote liver ischemic preconditioning (RLIPC) is an effective cardioprotective measure, reducing damage caused by subsequent cardiac I/R injury, but little is known about its potential role in pulmonary protection. Here, we analyzed the efficacy and mechanistic basis of RLIPC in a rat model of pulmonary I/R injury. RLIPC reduced lung I/R injury, lessening structural damage, inflammatory cytokine production and apoptosis. In addition, RLIPC preserved pulmonary function compared to controls following lung I/R injury. RLIPC stimulated phosphorylation of pulmonary STAT3, a component of the SAFE signaling pathway, but not phosphorylation of RISK pathway signaling proteins. Accordingly, STAT3 inhibition using AG490 eliminated the pulmonary protection afforded by RLIPC. Our data demonstrate for the first time that RLIPC protects agains...Continue Reading

References

Nov 1, 1985·The Journal of Clinical Investigation·E Braunwald, R A Kloner
Feb 1, 1967·Diseases of the Chest·A W Templeton, L J Garrotto
Nov 26, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C PeraltaJ Roselló-Catafau
May 12, 2005·Trends in Cardiovascular Medicine·Derek J HausenloyDerek M Yellon
May 29, 2007·Cellular and Molecular Life Sciences : CMLS·J E Forde, T C Dale
Mar 26, 2009·Journal of Molecular and Cellular Cardiology·Sandrine Lecour
Oct 1, 2009·The Biochemical Journal·Jad WaltersA Clay Clark
Sep 14, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Willem A den HengstAn L Moens
Dec 16, 2010·The Journal of Clinical Investigation·Daniel KreiselAndrew E Gelman
May 3, 2011·American Journal of Respiratory Cell and Molecular Biology·Gustavo Matute-BelloUNKNOWN Acute Lung Injury in Animals Study Group
Oct 9, 2012·Seminars in Cardiothoracic and Vascular Anesthesia·Paul D WeykerBrigid C Flynn
Jul 16, 2014·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Enjarn LinPaul S Myles
Sep 6, 2014·Cold Spring Harbor Perspectives in Biology·Toshio TanakaTadamitsu Kishimoto
Jun 20, 2015·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·José García-de-la-AsunciónJavier Belda
Aug 12, 2015·Current Opinion in Organ Transplantation·Mary K PorteousJason D Christie
Mar 6, 2016·Current Opinion in Organ Transplantation·Victor E Laubach, Ashish K Sharma
Mar 10, 2016·Cardiovascular Research·Zhaoyang HuGeoffrey W Abbott
Jan 1, 2017·American Journal of Physiology. Heart and Circulatory Physiology·Sabine GentGerd Heusch
May 30, 2017·Advances in Experimental Medicine and Biology·Giampaolo MorcianoPaolo Pinton
Oct 19, 2017·Cardiovascular Research·Matthew J StroudJu Chen

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

ImageJ

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.